Imaging Comparison for the Preoperative Planning and Diagnosis of DIE: a Multicenter Retrospective Study.

Launched by ZIEKENHUIS OOST-LIMBURG · May 20, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how well two different imaging methods—transvaginal ultrasound (TVS) and magnetic resonance imaging (MRI)—work for diagnosing deep infiltrating endometriosis (DIE) before surgery. The goal is to find out how well each method detects lesions that could affect treatment plans, especially when multiple doctors, like urologists and surgeons, need to work together. The study will evaluate TVS's effectiveness and see if having an MRI provides any additional useful information for planning surgery.

To participate in this trial, women aged 65 to 74 who are scheduled for surgery for DIE and have undergone imaging at specific hospitals in Belgium may be eligible. They should have a TVS report confirming the diagnosis of DIE. It's important to note that the imaging must be done by experienced professionals, and participants will have their surgery performed by skilled surgeons. Throughout the study, patients can expect thorough preoperative counseling based on their imaging results to help them understand what to expect from their surgery.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • All patients who underwent preoperative imaging at AZ Sint-Jan AV and Ziekenhuis Oost-Limburg (ZOL) between October 2021 and December 2024, TVS with or without complementary MR followed by therapeutic surgery as part of DIE.
• Exclusion Criteria:
• • Performing imaging, TVS with or without additional MR, by an operator without specific experience in the field.
• • Lack of a TVS report diagnosing DIE.
• • Preoperative diagnosis of only superficial endometriosis and/or endometriomas without DIE.
• • Performance of surgery by a surgeon without specific experience in the field.
• • Lack of a surgical report that correctly describes all DIE lesions.